We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCK icon
151
Crown Holdings
CCK
$12.8B
$1.05M 0.03%
10,488
+4,568
+77% +$420K
SPGI icon
152
S&P Global
SPGI
$126B
$991K 0.03%
3,014
+1,251
+71% +$422K
CTLT
153
DELISTED
CATALENT, INC.
CTLT
$975K 0.03%
9,365
-358
-4% -$34.7K
CNK icon
154
Cinemark Holdings
CNK
$3.82B
$971K 0.03%
+55,770
New +$701K
MTCH icon
155
Match Group
MTCH
$8.84B
$957K 0.03%
6,331
-234
-4% -$31K
SYNH
156
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$943K 0.03%
13,843
+2,595
+23% +$162K
DLTR icon
157
Dollar Tree
DLTR
$23.1B
$923K 0.03%
8,544
-323
-4% -$32.4K
MASS icon
158
908 Devices
MASS
$293M
$920K 0.03%
+16,157
New +$944K
BALL icon
159
Ball Corp
BALL
$17B
$898K 0.03%
9,639
+2,452
+34% +$227K
TRMB icon
160
Trimble
TRMB
$12.3B
$894K 0.03%
13,382
-461
-3% -$26.5K
TWLO icon
161
Twilio
TWLO
$29.1B
$890K 0.03%
2,629
+398
+18% +$124K
HUBS icon
162
HubSpot
HUBS
$10.5B
$875K 0.03%
2,206
-68
-3% -$23.9K
ROKU icon
163
Roku
ROKU
$21.1B
$862K 0.03%
2,597
+1,026
+65% +$269K
PINS icon
164
Pinterest
PINS
$12.4B
$854K 0.03%
+12,962
New +$778K
BKNG icon
165
Booking.com
BKNG
$138B
$853K 0.03%
9,575
+3,500
+58% +$270K
LULU icon
166
lululemon athletica
LULU
$13B
$849K 0.03%
2,439
-75
-3% -$26K
PPLI
167
People Inc
PPLI
$3.1B
$845K 0.03%
8,181
+2,604
+47% +$200K
V icon
168
Visa
V
$677B
$831K 0.03%
3,799
-927
-20% -$190K
BBBY
169
Bed Bath & Beyond
BBBY
$473M
$797K 0.03%
18,285
+6,619
+57% +$392K
MDB icon
170
MongoDB
MDB
$24B
$783K 0.03%
2,181
-68
-3% -$19K
SI
171
DELISTED
Silvergate Capital Corporation
SI
$774K 0.03%
+10,414
New +$343K
VRSK icon
172
Verisk Analytics
VRSK
$26.4B
$757K 0.03%
3,649
-1,113
-23% -$216K
AYX
173
DELISTED
Alteryx Inc
AYX
$756K 0.03%
+6,206
New +$782K
AZO icon
174
AutoZone
AZO
$48.3B
$737K 0.02%
622
-14
-2% -$16.2K
MRVI icon
175
Maravai LifeSciences
MRVI
$997M
$720K 0.02%
+25,656
New +$714K
5 6
7
8 9

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.